New gout drug ABP-671 shows promise in lowering uric acid
Disease control
Completed
This study tested a new drug, ABP-671, for people with gout. Gout causes painful joint swelling due to high uric acid levels. The trial involved 300 adults and compared different doses of ABP-671 to a placebo and an older drug called allopurinol. The main goal was to see if ABP-6…
Phase: PHASE2, PHASE3 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC